Dilafor AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Holding
- Established
- 2003-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.dilafor.com
Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix
- First Posted Date
- 2019-06-27
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Dilafor AB
- Target Recruit Count
- 347
- Registration Number
- NCT04000438
- Locations
- 🇸🇪
Förlossningsavdelningen Akademiska Universitetssjukhuset, Uppsala, Sweden
🇫🇮Naistenklinikka (HUS), Helsinki, Finland
🇸🇪Lund University Hospital, Lund, Sweden
Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2020-04-29
- Lead Sponsor
- Dilafor AB
- Target Recruit Count
- 361
- Registration Number
- NCT03001193
- Locations
- 🇫🇮
Kätilöopiston Sairaala (HUS), Helsinki, Finland
🇫🇮Tampere University Hospital, Tampere, Finland
🇫🇮Naistenklinikka (HUS) Naistentaudit ja synnytykset, Helsinki, Finland
Study to Assess Safety and Efficacy of DF01 in Reducing Prolonged Labor
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2009-05-19
- Lead Sponsor
- Dilafor AB
- Target Recruit Count
- 263
- Registration Number
- NCT00710242
- Locations
- 🇸🇪
Lanssjukhuset, Kalmar, Sweden
🇸🇪Kvinnokliniken Alvsborgs sjukhus Boras, Boras, Sweden
🇸🇪Lanssjukhuset Ryhov, Jonkoping, Sweden
© Copyright 2024. All Rights Reserved by MedPath